ANA has a long history serving as a classical clinical marker for the detection and screening of autoantibodies in autoimmune diseases including SLE, however, the sensitivity as well as accuracy of the ANA tests in diagnosis is not satisfactory due to false positives and negatives in previous reports (92–95). The gene discussed is BTG3; the disease is systemic lupus erythematosus.